Cargando...
Evaluation of the structural, physicochemical, and biological characteristics of SB4, a biosimilar of etanercept
A biosimilar is a biological medicinal product that is comparable to a reference medicinal product in terms of quality, safety, and efficacy. SB4 was developed as a biosimilar to Enbrel® (etanercept) and was approved as Benepali®, the first biosimilar of etanercept licensed in the European Union (EU...
Guardado en:
| Publicado en: | MAbs |
|---|---|
| Autores principales: | , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Taylor & Francis
2016
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4968139/ https://ncbi.nlm.nih.gov/pubmed/27246928 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19420862.2016.1193659 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|